{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:38:41Z","timestamp":1793144321497,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jtha.2022.10.022","type":"journal-article","created":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T06:17:53Z","timestamp":1673158673000},"page":"145-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["Communication from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis on sepsis-induced coagulopathy in the management of sepsis"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0255-4088","authenticated-orcid":false,"given":"Toshiaki","family":"Iba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2212-5299","authenticated-orcid":false,"given":"Marcel","family":"Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7218-0993","authenticated-orcid":false,"given":"Jecko","family":"Thachil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Helms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0895-6800","authenticated-orcid":false,"given":"Ecaterina","family":"Scarlatescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3766-4962","authenticated-orcid":false,"given":"Jerrold H.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2022.10.022_bib1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.thromres.2015.05.022","article-title":"Management of disseminated intravascular coagulation: a survey of the International Society on Thrombosis and Haemostasis","volume":"136","author":"Di Nisio","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2022.10.022_bib2","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","article-title":"Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation","volume":"86","author":"Taylor","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.10.022_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017046","article-title":"New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey","volume":"7","author":"Iba","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.jtha.2022.10.022_bib4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ams2.411","article-title":"Japanese Surviving Sepsis Campaign Guideline Working Group for disseminated intravascular coagulation. Diagnosis of sepsis-induced disseminated intravascular coagulation and coagulopathy","volume":"6","author":"Iba","year":"2019","journal-title":"Acute Med Surg"},{"key":"10.1016\/j.jtha.2022.10.022_bib5","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1111\/jth.14578","volume":"17","author":"Iba","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.10.022_bib6","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/jth.14482","article-title":"Scientific and Standardization Committee on DIC of the International Society on Thrombosis and Haemostasis. Proposal of a two-step process for the diagnosis of sepsis-induced disseminated intravascular coagulation","volume":"17","author":"Iba","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.10.022_bib7","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1097\/ALN.0000000000003122","article-title":"Sepsis-induced coagulopathy and disseminated intravascular coagulation","volume":"132","author":"Iba","year":"2020","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jtha.2022.10.022_bib8","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1182\/blood-2015-11-680744","article-title":"Molecular Diagnosis and Risk Stratification of Sepsis Consortium. Thrombocytopenia is associated with a dysregulated host response in critically ill sepsis patients","volume":"127","author":"Claushuis","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.10.022_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.thromres.2019.07.002","volume":"181","author":"Matsubara","year":"2019","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2022.10.022_bib10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12879-020-4853-y","article-title":"Plasma Hsa-miR-92a-3p in correlation with lipocalin-2 is associated with sepsis-induced coagulopathy","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jtha.2022.10.022_bib11","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/jth.14817","article-title":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","volume":"18","author":"Tang","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.10.022_bib12","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/bjh.17273","article-title":"Irish COVID-19 Vasculopathy Study (ICVS) Investigators. Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID-19): evidence of acute and sustained endothelial cell activation","volume":"192","author":"Ward","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2022.10.022_bib13","doi-asserted-by":"crossref","DOI":"10.1177\/1076029620987629","article-title":"Systemic coagulopathy in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis","volume":"27","author":"Uaprasert","year":"2021","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jtha.2022.10.022_bib14","article-title":"A\u00a0machine-learning approach for dynamic prediction of sepsis-induced coagulopathy in critically ill patients with sepsis","volume":"7","author":"Zhao","year":"2021","journal-title":"Front Med (Laussane)"},{"key":"10.1016\/j.jtha.2022.10.022_bib15","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/jamainternmed.2021.6203","article-title":"Efficacy and safety of therapeutic-dose heparin vs standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with COVID-19: the HEP-COVID randomized clinical trial","volume":"181","author":"Spyropoulos","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jtha.2022.10.022_bib16","article-title":"Favorable outcomes of anticoagulation with unfractioned heparin in sepsis-induced coagulopathy: a retrospective analysis of MIMIC-III database","volume":"8","author":"Peng","year":"2022","journal-title":"Front Med (Laussane)"},{"key":"10.1016\/j.jtha.2022.10.022_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-059383","article-title":"Comparison of standard prophylactic, intermediate prophylactic and therapeutic anticoagulation in patients with severe COVID-19: protocol for the ANTICOVID multicentre, parallel-group, open-label, randomised controlled trial","volume":"12","author":"Labbe","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.jtha.2022.10.022_bib18","doi-asserted-by":"crossref","DOI":"10.1177\/10760296221102929","article-title":"Clinical efficacy of soluble thrombomodulin, tissue plasminogen activator inhibitor complex, thrombin-antithrombin complex,\u03b12-plasmininhibitor-plasmin complex in pediatric sepsis","volume":"28","author":"Li","year":"2022","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jtha.2022.10.022_bib19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1055\/s-0038-1676610","article-title":"External validation of the two newly proposed criteria for assessing coagulopathy in sepsis","volume":"119","author":"Yamakawa","year":"2019","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.10.022_bib20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1055\/s-0040-1718736","article-title":"Evaluation of sepsis-induced coagulopathy in critically ill pediatric patients with septic shock","volume":"121","author":"Jhang","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.10.022_bib21","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1111\/jth.15500","article-title":"Clinical value of pediatric sepsis-induced coagulopathy score in diagnosis of sepsis-induced coagulopathy and prognosis in children","volume":"19","author":"Xiang","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.10.022_bib22","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2019.5358","article-title":"Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: the SCARLET randomized clinical trial","volume":"321","author":"Vincent","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2022.10.022_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13613-021-00842-4","article-title":"Efficacy and safety of human soluble thrombomodulin (ART-123) for treatment of patients in France with sepsis-associated coagulopathy: post hoc analysis of SCARLET","volume":"11","author":"Fran\u00e7ois","year":"2021","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.jtha.2022.10.022_bib24","doi-asserted-by":"crossref","DOI":"10.1177\/1076029618824044","article-title":"Usefulness of measuring changes in SOFA score for the prediction of 28-day mortality in patients with sepsis-associated disseminated intravascular coagulation","volume":"25","author":"Iba","year":"2019","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jtha.2022.10.022_bib25","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1177\/1076029618770273","article-title":"Sepsis-induced coagulopathy and Japanese Association for acute medicine DIC in coagulopathic patients with decreased antithrombin and treated by antithrombin","volume":"24","author":"Iba","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jtha.2022.10.022_bib26","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1177\/0885066618773679","article-title":"Newly proposed sepsis-induced coagulopathy precedes International Society on Thrombosis and Haemostasis overt-disseminated intravascular coagulation and predicts high mortality","volume":"35","author":"Iba","year":"2020","journal-title":"J\u00a0Intensive Care Med"},{"key":"10.1016\/j.jtha.2022.10.022_bib27","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/MBC.0000000000000755","article-title":"Comparison of a new criteria for sepsis-induced coagulopathy and International Society on Thrombosis and Haemostasis disseminated intravascular coagulation score in critically ill patients with sepsis 3.0: a retrospective study","volume":"29","author":"Ding","year":"2018","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jtha.2022.10.022_bib28","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13613-020-00704-5","article-title":"Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis). Performances of disseminated intravascular coagulation scoring systems in septic shock patients","volume":"10","author":"Helms","year":"2020","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.jtha.2022.10.022_bib29","doi-asserted-by":"crossref","first-page":"e671","DOI":"10.1016\/S2352-3026(20)30217-9","article-title":"Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study","volume":"7","author":"Liao","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtha.2022.10.022_bib30","article-title":"Development of a nomogram to predict 28-day mortality of patients with sepsis-induced coagulopathy: an analysis of the MIMIC-III database","volume":"8","author":"Lu","year":"2021","journal-title":"Front Med (Laussane)"},{"key":"10.1016\/j.jtha.2022.10.022_bib31","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12185-021-03152-4","article-title":"Validation of sepsis-induced coagulopathy score in critically ill patients with septic shock: post hoc analysis of a nationwide multicenter observational study in Japan","volume":"114","author":"Tanaka","year":"2021","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtha.2022.10.022_bib32","first-page":"102","article-title":"Diagnostic and prognostic value of sepsis-induced coagulopathy and International Society on Thrombosis and Hemostasis scoring systems in COVID-19-associated disseminated intravascular coagulopathy","volume":"26","author":"Hosseini","year":"2021","journal-title":"J\u00a0Res Med Sci"},{"key":"10.1016\/j.jtha.2022.10.022_bib33","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.5005\/jp-journals-10071-24056","article-title":"Disseminated intravascular coagulation score and sepsis-induced coagulopathy score in prediction of COVID-19 severity: a retrospective analysis","volume":"25","author":"Kapoor","year":"2021","journal-title":"Indian J Crit Care Med"},{"key":"10.1016\/j.jtha.2022.10.022_bib34","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1272\/jnms.JNMS.2022_89-506","article-title":"Coagulation influencing liberation from respiratory support in patients with coronavirus disease 2019: a retrospective, observational study","volume":"89","author":"Shinada","year":"2022","journal-title":"J\u00a0Nippon Med Sch"},{"key":"10.1016\/j.jtha.2022.10.022_bib35","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1055\/s-0039-1693740","article-title":"Identifying sepsis populations benefitting from anticoagulant therapy: a prospective cohort study incorporating a restricted cubic spline regression model","volume":"119","author":"Yamakawa","year":"2019","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.10.022_bib36","doi-asserted-by":"crossref","first-page":"108","DOI":"10.5114\/ait.2021.106691","article-title":"SIC or CAC - the haemostatic profile in COVID-19 patients hospitalised in the intensive care unit: a single-centre retrospective analysis","volume":"53","author":"Pluta","year":"2021","journal-title":"Anaesthesiol Intensive Ther"},{"key":"10.1016\/j.jtha.2022.10.022_bib37","first-page":"2875","article-title":"Hematological phenotype of COVID-19-induced coagulopathy: far from typical sepsis-induced coagulopathy","volume":"9","author":"Umemura","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jtha.2022.10.022_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2020.100742","article-title":"Thrombosis and coagulopathy in COVID-19","volume":"46","author":"G\u00f3mez-Mesa","year":"2021","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.jtha.2022.10.022_bib39","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00134-017-4725-0","article-title":"What do sepsis-induced coagulation test result abnormalities mean to intensivists?","volume":"43","author":"Levi","year":"2017","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jtha.2022.10.022_bib40","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1097\/01.CCM.0000147769.07699.E3","article-title":"Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation","volume":"32","author":"Bakhtiari","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jtha.2022.10.022_bib41","first-page":"1028","article-title":"Proposal of quick diagnostic criteria for disseminated intravascular coagulation","volume":"11","author":"Wada","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jtha.2022.10.022_bib42","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/CCM.0000000000004426","article-title":"Effect of a recombinant human soluble thrombomodulin on baseline coagulation biomarker levels and mortality outcome in patients with sepsis-associated coagulopathy","volume":"48","author":"Levi","year":"2020","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jtha.2022.10.022_bib43","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1177\/1076029618757346","article-title":"Optimal antithrombin activity threshold for initiating antithrombin supplementation in patients with sepsis-induced disseminated intravascular coagulation: a multicenter retrospective observational study","volume":"24","author":"Hayakawa","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jtha.2022.10.022_bib44","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1001\/jama.286.15.1869","article-title":"Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial","volume":"286","author":"Warren","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2022.10.022_bib45","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1202290","article-title":"Drotrecogin alfa (activated) in adults with septic shock","volume":"366","author":"Ranieri","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2022.10.022_bib46","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jama.290.2.238","article-title":"Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial","volume":"290","author":"Abraham","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2022.10.022_bib47","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/s-0038-1676345","article-title":"Recombinant human soluble thrombomodulin in sepsis-induced coagulopathy: an updated systematic review and meta-analysis","volume":"119","author":"Yamakawa","year":"2019","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.10.022_bib48","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/jth.13950","article-title":"Antithrombin concentrate use in disseminated intravascular coagulation of sepsis: meta-analyses revisited","volume":"16","author":"Wiedermann","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.10.022_bib49","doi-asserted-by":"crossref","first-page":"e659","DOI":"10.1002\/ams2.659","article-title":"The Japanese clinical practice guidelines for management of sepsis and septic shock 2020 (J-SSCG 2020)","volume":"8","author":"Egi","year":"2021","journal-title":"Acute Med Surg"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622071926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622071926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:33:33Z","timestamp":1761536013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622071926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1538783622071926"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2022.10.022","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Communication from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis on sepsis-induced coagulopathy in the management of sepsis","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2022.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}